Daniel P. Gold Ph.D. is CEO at MEI Pharma, Inc. (MEIP). They have made 1 open-market trade across 1 company since 2019, most recently 2021-07-02.
CIK 0001288233
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $30K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MEIP | BUY | 2019-12-19 | 2019-12-20 | $1.60 | $30K | +21.1% | +27.4% | -49.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.